YEM Search

搜索结果

SLC4A4

靶点ID:TCMBANKGE004237

靶点别名:HNBC1; KNBC; NBC1; NBC2; NBCe1-A; SLC4A5; hhNMC; kNBC1; pNBC

靶点描述:solute carrier family 4 member 4

染色体:4

染色体位置:4q13.3

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:11030

OMIM_Link:603345

Ensembl_Link:ENSG00000080493

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN022518	noradrenaline	l-Norepinephrine bitartrate; 33404-26-1; l-Arterenol d-bitartrate; Norepinephrine hydrogen tartrate; 350-25-4; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt); API0007150; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 341N180; L(+)-TARTARIC ACID; NOREPINEPHRINE; Noradrenalin bitartrate, l-; Arterenol bitartrate; Noradrenaline acid tartrate; MolPort-029-943-999; Norartrinal bitartrate; Levarterenol; ZW81GF408B; Norepinephrine bitartrate anhydrous; L-Noradrenaline bitartrate; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol (L-(+))-bitartrate salt; AKOS007930222; Noradrenaline, tartrate (1:1); Norepinephrine tartrate; 73-98-3; Noradrenaline bitartrate; Noradrenaline tartrate; l-Noradrenaline tartrate; UNII-ZW81GF408B; C8H11NO3.C4H6O6; (-)-Norepinephrine bitartrate; (-)-Noradrenaline (+)-bitartrate; BG01031160; 51-40-1; 2477-42-1; Levonorepinephrine; 2595AH; l-Noradrenaline d-bitartrate; Noradrenaline hydrogen tartrate; HMS2089E22; (-)-R-Norepinephrine bitartrate; NSC 169106; 51-41-2 (Parent); API0003624; norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (R-(R,R))-2,3-dihydroxybutanedioate (1:1); l-Arterenol bitartrate; Levarterenol bitartrate; Noradrenalin bitartrate; L-(-)-Noradrenaline (+)-bitartrate salt monohydrate; BENZYL ALCOHOL, alpha-(AMINOMETHYL)-3,4-DIHYDROXY-, (-)-, TARTRATE (1:1); 24868-01-7; 893-91-4; EINECS 200-095-0	C8H12NO3+	170.19 g/mol	C1=CC(=C(C=C1C(C[NH3+])O)O)O
TCMBANKIN057911	se	selenium	H2Se	78.97 g/mol	[Se]
TCMBANKIN059684	Vitamin E β-		C29H50O2	430.79	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O
TCMBANKIN059746	α-tocopherol		C29H50O2	430.7 g/mol	CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C
TCMBANKIN061279	Diethyl ether		C4H10O	74.12 g/mol	CCOCC

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000653		Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI002054		Eye Diseases	Abnormality of the eye	Finding	phenotype
TCMBANKDI002572		-	-	Finding	disease
TCMBANKDI007543		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	Abnormality of metabolism/homeostasis; Abnormality of the genitourinary system	Disease or Syndrome	disease
TCMBANKDI012151		Respiratory Tract Diseases; Immune System Diseases	-	Disease or Syndrome	disease
TCMBANKDI021831		Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	Abnormality of the endocrine system	Disease or Syndrome	disease
TCMBANKDI028744		Nutritional and Metabolic Diseases	Abnormality of metabolism/homeostasis	Disease or Syndrome	phenotype
TCMBANKDI028908		Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases	Abnormality of the eye	Disease or Syndrome	phenotype
TCMBANKDI029520		Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI030688		-	-	Anatomical Abnormality	phenotype
TCMBANKDI031189		Neoplasms	Neoplasm; Abnormality of the respiratory system	Neoplastic Process	disease
TCMBANKDI031570		-	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease